# HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

> **NCT00855413** · PHASE4 · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 15 (actual)

## Conditions studied

- Acute HIV Infection
- HIV Infections

## Interventions

- **DRUG:** Darunavir
- **DRUG:** Ritonavir
- **DRUG:** Etravirine

## Key facts

- **NCT ID:** NCT00855413
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** Study halted by sponsor due to slow enrollment.
- **Last updated:** 2017-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00855413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00855413, "HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00855413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*